e-Algerian Journal of Health & Research
Volume 2, Numéro 1, Pages 110-113
2025-12-18
Authors : Hadjeb Asma . Si Ali Nadjat . Tayebi Karima . Chereti Malika . Ramdoum Amina . Benlazar Mohamed .
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a biologically distinct entity in the 2022 WHO classification and is associated with a poor prognosis due to its resistance to chemotherapy and high relapse rate. Targeting oncogenic proteins of the BCL-2 family with agents such as Venetoclax offers a therapeutic alternative for patients with refractory or relapsed disease. In this case report, we describe a patient with relapsed disease refractory to standard treatment, who was managed with a short course of Venetoclax.
Early T-cell precursor acute lymphoblastic leukemia , ETP-ALL, Venetoclax.
Cherif Hosni Aicha
.
Kehal Samia
.
Meghrebi Sara
.
Lahmer Imene
.
Messaoudi Reda
.
pages 452-459.
Bekadja Mohamed-amine
.
Mansour Belkacem
.
Ouldjeriouat Hafida
.
Entasoltan Badra
.
Osmani Soufi
.
Amani Kamila
.
Bouchama Samira
.
Charef Leila
.
Brahimi Mohamed
.
Arabi Abdessamed
.
Bouhass Rachid Amar
.
Yafour Nabil
.
pages 747-754.
Boudghene Stambouli A.
.
Djerroud S.
.
pages 267-284.
Nachi Mourad
.
Kihek Ibtissem
.
Entasoltan Badra
.
Taibi Karima
.
Guella Mohamed Djaoued
.
Abed Amine
.
Boukhatmi Yasmine
.
Bekadja Mohamed Amine
.
pages 527-532.